Overview
ISO 10993-12:2021/Amd 1:2025 is an important amendment to the International Standard ISO 10993-12, which focuses on the biological evaluation of medical devices. Specifically, Part 12 addresses sample preparation and reference materials necessary for assessing the biological safety of medical devices. This 2025 amendment refines and updates procedures and requirements to ensure greater accuracy and consistency during the sample processing stages in biological evaluations.
As medical devices come into direct or indirect contact with tissues, rigorous testing is critical to verify their biocompatibility. This amendment supports those efforts by clarifying standards for material extraction and sample handling, playing a vital role in risk management and regulatory compliance.
Key Topics
-
Sample Preparation
The amendment updates protocols for preparing samples extracted from medical device materials. It emphasizes the need to consider material characteristics such as thickness and absorbency to determine appropriate extraction volumes.
-
Reference Materials
Establishes guidelines on the use of reference materials to guarantee consistency and reliability in biological evaluation tests.
-
Extraction Ratios
Provides revised tables and recommendations on standard surface areas and extraction liquid volumes, accounting for different material forms such as films, sheets, elastomers, powders, and porous devices.
-
Absorbent Material Considerations
Introduces specific guidance for handling absorbent medical device materials. Testing protocols should take into account the individual absorption capacity of these materials for accurate extraction.
-
Cross-References with Related Standards
The amendment aligns with key standards like ISO 10993-1 for biological evaluation processes, ISO 10993-18 and ISO/TS 10993-19 for chemical and morphological characterization, and ISO 14971 concerning risk management for medical devices.
Applications
ISO 10993-12:2021/Amd 1:2025 provides vital practical value in the following areas:
-
Medical Device Manufacturers
Ensures sample preparation methods used in biocompatibility testing comply with recognized international requirements, facilitating regulatory approvals globally.
-
Testing Laboratories
Offers standardized procedures that improve reproducibility and accuracy when extracting test samples from device materials, including complex absorbent materials.
-
Regulatory Compliance
Helps manufacturers meet international regulatory demands for demonstrating biological safety based on validated sample processing methods.
-
Risk Management
Supports comprehensive risk assessments by linking sample preparation protocols with overall biological evaluation strategies and material characterization.
Related Standards
To understand and implement ISO 10993-12:2021/Amd 1:2025 effectively, it is essential to consider the following related standards:
- ISO 10993-1:2020 – Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process
- ISO 10993-18:2020 – Biological evaluation of medical devices – Part 18: Chemical characterization of materials
- ISO/TS 10993-19:2023 – Biological evaluation of medical devices – Part 19: Physico-chemical, morphological, and topographical characterization
- ISO 14971:2019 – Medical devices – Application of risk management to medical devices
These standards complement the procedures detailed in ISO 10993-12 amendment by providing frameworks for risk management, chemical and physical assessment, and broader biological evaluation criteria.
Keywords: ISO 10993-12 amendment, biological evaluation, medical device testing, sample preparation, reference materials, medical device biocompatibility, extraction volume, absorbent materials, medical device standards, risk management in medical devices, ISO biological evaluation standards.
Open preview (PDF)Biological evaluation of medical devices — Part 12: Sample preparation and reference materials — Amendment 1
